During the past decade, Centrum Badan Klinicznych JCI conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on
average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE
A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Children and Young Adults
Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age
2021-04-09
2022-09-09
Completed
149
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Badan Klinicznych JCI"
#1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Centrum Badan Klinicznych JCI
According to Clinical.Site data, the most researched conditions in "Centrum Badan Klinicznych JCI" are
"Dermatitis, Atopic" (3 trials), "Meningococcal Vaccine" (3 trials), "Dermatitis" (1 trials), "Eczema" (1 trials) and "Genetic Diseases, Inborn" (1 trials). Many other conditions were trialed in "Centrum Badan Klinicznych JCI" in a lesser frequency.
Clinical Trials Intervention Types at Centrum Badan Klinicznych JCI
Most popular intervention types in "Centrum Badan Klinicznych JCI" are "Biological" (5 trials), "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials), "Trumenba" (2 trials) and "13-valent pneumococcal conjugate vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Centrum Badan Klinicznych JCI
The vast majority of trials in "Centrum Badan Klinicznych JCI" are
9 trials for "All" genders.
Clinical Trials Status at Centrum Badan Klinicznych JCI
Currently, there are NaN active trials in "Centrum Badan Klinicznych JCI".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Centrum Badan Klinicznych JCI,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Centrum Badan Klinicznych JCI, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".